VISAKHAPATNAM: For Roshni Aparanji Korati, the new assignment carries a sense of homecoming. Taking charge as Deputy ...
Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...
The program, which launches in the fall, includes different pathways to be industry-ready, ranging from micro-credentials to a full associate degree. A $3 million lab modeled on real industry ...
Emerging research in cellular reprogramming, gene editing, and regenerative medicine is driving interest in preventive longevity medicine. Some researchers argue aging may be treated as a modifiable ...
BioNTech continues to sharpen its strategic focus on the growing late-stage clinical pipeline spanning immunomodulator, ADC and mRNA ...
Synthetic biology is the design and construction of new biological parts, devices, and systems, and the re-design of existing, natural biological systems for useful purposes. In this Review, Teixeira ...
Relmada Therapeutics stock surged after reporting positive Phase 2 trial results for NDV-01 and announcing a $160 million ...
MiNK Therapeutics (INKT) surged in premarket trading after announcing a partnership with C-Further to develop a new pediatric cancer therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results